Correction to: Extended duration of treatment using reduced‑frequency dosing of anti‑PD‑1 therapy in patients with advanced melanoma and Merkel cell carcinoma

Lisa May Ling Tachiki^{1

2}, Daniel S Hippe³, Karly Williams Silva^{4

3}, Evan Thomas Hall^{4

3}, William McCamy⁴, Dane Fritzsche³, Andrea Perdue^{4

3}, Julia Majovski^{4

3}, Thomas Pulliam^{5

3}, Daniel A Goldstein⁶, Joshua Veatch^{4

3}, Joel Ho^{4

3}, Paul T Nghiem^{5

3}, John A Thompson^{4

3}, Shailender Bhatia^{7

8}

Affiliations

¹ Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA. ltachiki@uw.edu.
² Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. ltachiki@uw.edu.
³ Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
⁴ Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.
⁵ Department of Medicine, Division of Dermatology, University of Washington, Seattle, WA, USA.
⁶ Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel.
⁷ Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA. sbhatia@uw.edu.
⁸ Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. sbhatia@uw.edu.

Published Erratum

Lisa May Ling Tachiki et al. Cancer Immunol Immunother. 2023 Dec.

. 2023 Dec;72(12):4471.

doi: 10.1007/s00262-023-03575-4.

¹ Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA. ltachiki@uw.edu.
² Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. ltachiki@uw.edu.
³ Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
⁴ Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.
⁵ Department of Medicine, Division of Dermatology, University of Washington, Seattle, WA, USA.
⁶ Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel.
⁷ Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA. sbhatia@uw.edu.
⁸ Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. sbhatia@uw.edu.

No abstract available

Erratum for

Extended duration of treatment using reduced-frequency dosing of anti-PD-1 therapy in patients with advanced melanoma and Merkel cell carcinoma.
Tachiki LML, Hippe DS, Williams Silva K, Hall ET, McCamy W, Fritzsche D, Perdue A, Majovski J, Pulliam T, Goldstein DA, Veatch J, Ho J, Nghiem PT, Thompson JA, Bhatia S. Tachiki LML, et al. Cancer Immunol Immunother. 2023 Nov;72(11):3839-3850. doi: 10.1007/s00262-023-03539-8. Epub 2023 Sep 21. Cancer Immunol Immunother. 2023. PMID: 37733060 Free PMC article.